Total Payments
$7,257
2024 Payments
$2,715
Companies
21
Transactions
229
Medicare Patients
3,997
Medicare Billing
$362,876
Payment Breakdown by Category
Food & Beverage$6,947 (95.7%)
Education$179.00 (2.5%)
Other$131.09 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,947 | 226 | 95.7% |
| Education | $179.00 | 2 | 2.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $131.09 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $2,030 | 34 | $0 (2024) |
| GENZYME CORPORATION | $1,157 | 27 | $0 (2024) |
| ABBVIE INC. | $966.57 | 47 | $0 (2024) |
| Janssen Biotech, Inc. | $529.53 | 25 | $0 (2024) |
| PFIZER INC. | $338.24 | 13 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $265.93 | 15 | $0 (2024) |
| Amgen Inc. | $253.74 | 6 | $0 (2024) |
| UCB, Inc. | $246.68 | 11 | $0 (2024) |
| Allergan, Inc. | $233.25 | 7 | $0 (2022) |
| Incyte Corporation | $198.15 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,715 | 120 | GENZYME CORPORATION ($670.37) |
| 2023 | $1,114 | 41 | ABBVIE INC. ($264.18) |
| 2022 | $557.31 | 18 | EPI Health, LLC ($158.73) |
| 2021 | $347.52 | 8 | Galderma Laboratories, L.P. ($192.50) |
| 2020 | $185.63 | 4 | Galderma Laboratories, L.P. ($164.20) |
| 2019 | $551.71 | 7 | Galderma Laboratories, L.P. ($551.71) |
| 2018 | $1,201 | 15 | Galderma Laboratories, L.P. ($867.47) |
| 2017 | $585.45 | 16 | Allergan Inc. ($162.89) |
All Payment Transactions
229 individual payment records from CMS Open Payments — Page 4 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.36 | General |
| Category: IMMUNOLOGY | ||||||
| 06/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.06 | General |
| Category: IMMUNOLOGY | ||||||
| 06/11/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Dermatology | ||||||
| 06/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $35.86 | General |
| Category: Immunology | ||||||
| 05/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: IMMUNOLOGY | ||||||
| 05/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.04 | General |
| Category: IMMUNOLOGY | ||||||
| 05/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: Immunology | ||||||
| 05/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: Dermatology | ||||||
| 05/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $1.63 | General |
| Category: Dermatology | ||||||
| 05/20/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: Inflammation | ||||||
| 05/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $125.87 | General |
| Category: Immunology | ||||||
| 05/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Immunology | ||||||
| 05/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.56 | General |
| Category: IMMUNOLOGY | ||||||
| 05/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $40.58 | General |
| Category: Immunology | ||||||
| 05/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.76 | General |
| Category: IMMUNOLOGY | ||||||
| 05/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $30.78 | General |
| Category: Immunology | ||||||
| 04/19/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: Inflammation | ||||||
| 04/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Immunology | ||||||
| 04/17/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Dermatology | ||||||
| 04/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Immunology | ||||||
| 04/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.56 | General |
| Category: Immunology | ||||||
| 04/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.87 | General |
| Category: Immunology | ||||||
| 04/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: IMMUNOLOGY | ||||||
| 04/01/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $29.32 | General |
| Category: Immunology | ||||||
| 04/01/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $1.17 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 656 | 1,052 | $87,536 | $52,363 |
| 2022 | 10 | 1,251 | 1,865 | $204,073 | $122,771 |
| 2021 | 10 | 1,210 | 1,778 | $196,654 | $119,230 |
| 2020 | 9 | 880 | 1,228 | $120,228 | $68,512 |
Total Patients
3,997
Total Services
5,923
Medicare Billing
$362,876
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 230 | 256 | $40,638 | $24,066 | 59.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 110 | $12,473 | $6,846 | 54.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 69 | 75 | $9,234 | $6,093 | 66.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 108 | 127 | $9,595 | $5,680 | 59.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 42 | 46 | $6,569 | $4,255 | 64.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 78 | 394 | $3,551 | $2,157 | 60.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $2,667 | $1,496 | 56.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 16 | 20 | $1,277 | $892.20 | 69.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $1,533 | $876.33 | 57.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 392 | 509 | $84,540 | $51,004 | 60.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 228 | 334 | $39,577 | $22,084 | 55.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 160 | 183 | $24,246 | $14,988 | 61.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 98 | 116 | $17,478 | $10,996 | 62.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 142 | 195 | $14,602 | $9,449 | 64.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 34 | 34 | $7,604 | $4,483 | 59.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 56 | 56 | $8,135 | $4,463 | 54.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 96 | 390 | $3,311 | $2,282 | 68.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 32 | 35 | $2,458 | $1,638 | 66.6% |
| 10060 | Simple or single drainage of skin abscess | Office | 2022 | 13 | 13 | $2,123 | $1,385 | 65.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 328 | 393 | $65,540 | $38,464 | 58.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 285 | 479 | $56,662 | $33,978 | 60.0% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 162 | 194 | $25,858 | $16,686 | 64.5% |
| 17000 | Destruction of skin growth | Office | 2021 | 133 | 183 | $13,954 | $8,795 | 63.0% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 71 | 91 | $13,671 | $8,303 | 60.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 83 | 83 | $12,318 | $7,184 | 58.3% |
About Dr. Anat Lebow, M.D
Dr. Anat Lebow, M.D is a Dermatology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1831211226.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anat Lebow, M.D has received a total of $7,257 in payments from pharmaceutical and medical device companies, with $2,715 received in 2024. These payments were reported across 229 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($6,947).
As a Medicare-enrolled provider, Lebow has provided services to 3,997 Medicare beneficiaries, totaling 5,923 services with total Medicare billing of $362,876. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location New York, NY
- Active Since 04/04/2007
- Last Updated 03/02/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1831211226
Products in Payments
- DUPIXENT (Biological) $1,031
- EPIDUO FORTE (Drug) $929.32
- TREMFYA (Drug) $417.67
- RINVOQ (Biological) $384.49
- SKYRIZI (Biological) $383.14
- AKLIEF (Drug) $339.54
- ORACEA (Drug) $329.02
- SOOLANTRA (Drug) $323.68
- Sotyktu (Drug) $265.93
- Otezla (Drug) $253.74
- CIBINQO (Drug) $220.88
- Bimzelx (Biological) $211.88
- OPZELURA (Drug) $198.15
- COSENTYX (Drug) $158.98
- RHOFADE (Drug) $155.89
- SILIQ (Drug) $150.23
- TALTZ (Drug) $136.21
- WYNZORA (Drug) $131.09
- EUCRISA (Drug) $117.36
- DUPIXENT (Drug) $116.69
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in New York
David Cohen, M.d, M.D
Dermatology — Payments: $3.1M
Dermatology $3.1M
Dr. Amy Wechsler, M.d, M.D
Dermatology — Payments: $2.8M
Dermatology $2.8M
Dr. Alexandra Golant, M.d, M.D
Dermatology — Payments: $2.7M
Dermatology $2.7M
Emma Guttman, Md, MD
Dermatology — Payments: $2.2M
Dermatology $2.2M
Dr. Joshua Zeichner, Md, MD
Dermatology — Payments: $2.1M
Dermatology $2.1M
Dr. Mark Lebwohl
Dermatology — Payments: $2.0M
Dermatology $2.0M